Abstract
Chromosomal regions of allelic imbalance in tumors are predicted to define the general location of tumor suppressor genes. We previously localized a putative breast tumor suppressor gene to a 3 cM region on 17q25 by deletion mapping of microsatellite markers in breast tumors. To determine if the same 17q25 region of loss is important in the genesis of other tumor types, 32 ovarian tumors and 24 prostate tumors, as well as 33 additional breast tumors, were analysed with 17q25 polymorphic microsatellite markers. While no significant loss was observed in prostate tumors, greater than half of ovarian tumors exhibited loss coincident with the candidate region previously defined in breast tumors. These results suggest that one or more novel tumor suppressor genes exist on 17q25 within a concordant region of interstitial loss defined in both breast and ovarian neoplasms.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalikin, L., Frank, T., Svoboda-Newman, S. et al. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors. Oncogene 14, 1991–1994 (1997). https://doi.org/10.1038/sj.onc.1201013
Received:
Revised:
Accepted:
Issue Date:
Keywords
- loss of heterozygosity
- ovarian
- breast
- prostate
- tumor suppressor
- chromosome 17q25
Further reading
-
Applying circulating tumor DNA methylation in the diagnosis of lung cancer
Precision Clinical Medicine (2019)
-
Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas
Acta Histochemica (2016)
-
Variation in Sp1 binding sites correlates with expression of survivin in breast cancer
Molecular Medicine Reports (2014)
-
Septin roles in tumorigenesis
Biological Chemistry (2011)
-
Conquering the complex world of human septins: implications for health and disease
Clinical Genetics (2010)